Factors Affecting the Risk of Infection
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
Development of Antibiotic Resistance
Healthcare Associated Infections II: Preventive Measures
Fungal Phylum Microsporidia
Transmission-based Precautions I: Contact, Enteric, and Droplets
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 5, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Tanya M Monaghan1, Rima Biswas2, Ashish Satav3
1NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.
Clostridioides difficile infection (CDI) is a significant health threat, yet data on its prevalence in India is scarce. Enhanced awareness and laboratory capacity are crucial for understanding and managing this neglected bacterial infection.
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: